Total Return chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:00 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.000 USD | -2.91% |
|
0.00% | -40.12% |
| 10-29 | Lineage Cell Therapeutics Provides Update On ReSonance Program For Hearing Loss | CI |
| 10-01 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
